Therapeutic Potential of Targeting Stromal Crosstalk-Mediated Immune Suppression in Pancreatic Cancer is a research paper published in Frontiers in Oncology (2021). On theSindex it has a DataRank of 1.0. It has been cited 23 times, with 22 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.477
From this paper's citation signal
Citation Network Contribution
0.533
From 19 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 22 citers.
NCI NIH HHS
Grant: R50 CA232985
National Institutes of Health
Grant: 5P30CA046592-23
HEALTH COMMUNICATIONS
National Institutes of Health
Grant: 1R01CA198074-01
Dosage-Dependent Hedgehog Signaling in Pancreatic Cancer
National Institutes of Health
Grant: 5R01CA151588-08
Mechanisms of Pancreatic Inflammation, Tissue Repair and Carcinogenesis
National Institutes of Health
Grant: 4U01CA224145-02
Interrupting Cellular Crosstalk in the Immunosuppressive Microenvironment of Pancreas Cancer
National Institutes of Health
Grant: 5R50CA232985-02
Targeting the Immunosuppressive Tumor Microenvironment in Pancreatic Cancer
FWCI
1.38
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals